Clinical Study
Oral Curcumin (Meriva) Is Effective as an Adjuvant Treatment and Is Able to Reduce IL-22 Serum Levels in Patients with Psoriasis Vulgaris
Table 2
Efficacy secondary end points at T12 and at T16.
| | | T12 | T16 | | | Arm 1 | Arm 2 | Arm 1 | Arm 2 |
| | PASI 50 | 23/25 (92%) | 13/24 (54%) | 22/25 (88%) | 11/24 (46%) | | PASI 75 | 12/25 (48%) | 3/24 (12%) | 11/25 (44%) | 2/24 (8%) | | PASI 90 | 5/25 (20%) | 1/24 (4%) | 2/25 (8%) | 0/24 (0%) | | PASI 100 | 3/25 (12%) | 1/24 (4%) | 1/25 (4%) | 0/24 (0%) |
|
|
